Submission Details
| 510(k) Number | K253517 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 12, 2025 |
| Decision Date | March 10, 2026 |
| Days to Decision | 118 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K253517 is an FDA 510(k) clearance for the Reselute Tibial Nail, a Rod, Fixation, Intramedullary And Accessories (Class II — Special Controls, product code HSB), submitted by Reselute, Inc. (Durham, US). The FDA issued a Cleared decision on March 10, 2026, 118 days after receiving the submission on November 12, 2025. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3020.
| 510(k) Number | K253517 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 12, 2025 |
| Decision Date | March 10, 2026 |
| Days to Decision | 118 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | HSB — Rod, Fixation, Intramedullary And Accessories |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3020 |